Innovation in pharma today means faster ‘time to insight’. However, trying to innovate with disconnected, fragmented data is slow, costly and frustrating—for both pharma companies and patients. In this paper, industry leaders weigh in on what’s preventing pharma companies from escaping data silos and a new way forward.